Schedule 13G ownership disclosure
SCILEX HOLDING CO
Common Stock, par value $0.0001 per share · CUSIP: 80880W205
Event date: 2025-09-30
- Filing-level shares
- 833,473
- Percent of class
- 9.9%
- Oramed Pharmaceuticals Inc.
Shares: 833,473 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001012975-25-000769
- Form type
- SCHEDULE 13G/A
- Filer
- ORAMED PHARMACEUTICALS INC.
- CIK
- CIK 1176309
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership